Newsfeed : Study: Neglecting IV Drug Users Drives New HIV Infections Worldwide

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » March 2010

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 2, 2010

Study: Neglecting IV Drug Users Drives New HIV Infections Worldwide

Governments that offer no HIV prevention programming for injection drug users face a potentially devastating public health crisis of increasing HIV incidence, according to a study published in The Lancet medical journal and reported by Reuters. UNAIDS estimates that about 30 percent of HIV transmission outside of sub-Saharan Africa is driven by unsafe injection drug use practices.

“Although the number of countries with core HIV prevention services is growing, the level of coverage in injecting drug users is poor in many countries,” said Bradley Mathers of the University of New South Wales, Australia, who led the study. The study calls HIV among drug users a “critical health problem” in countries such as Russia, China, Malaysia and Thailand.

Experts recommend governments take prevention or harm reduction steps such as providing clean needles, condoms and methadone to reduce the spread of HIV/AIDS.

“HIV prevention treatment and care services for injecting drug users are clinically effective, but to exert a population-level effect they need to be delivered to scale,” researchers wrote. The current level is “not sufficient to prevent, halt or turn around the HIV epidemic among this at-risk population.”

Search: intravenous, drug users, sub-Saharan Africa, condoms, needles, methadone, University of New South Wales, Australia, The Lancet, Russia, China, Malaysia, Thailand


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    charliehunter
    San Francisco
    California


    Newhopenate
    New Hope
    Pennsylvania


    TaintedloveDC
    Washington
    DC


    humboman
    Baltimore
    Maryland
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.